Crossmark

Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model

Crossref DOI link: https://doi.org/10.1007/s13311-023-01434-9

Published Print: 2023-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Donohue, Katherine J.

Fitzsimmons, Bethany

Bruntz, Ronald C.

Markussen, Kia H.

Young, Lyndsay E.A.

Clarke, Harrison A.

Coburn, Peyton T.

Griffith, Laiken E.

Sanders, William

Klier, Jack

Burke, Sara N.

Maurer, Andrew P.

Minassian, Berge A.

Sun, Ramon C.

Kordasiewisz, Holly B.

Gentry, Matthew S. https://orcid.org/0000-0001-5253-9049
Funding

Funding for this research was provided by:

Ionis Pharmaceuticals
License Information

Text and Data Mining valid from 2023-10-01

Text and Data Mining valid from 2023-10-01

Version of Record valid from 2023-10-23
More Information

This article is maintained by: Elsevier

Article Title: Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model

Journal Title: Neurotherapeutics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-023-01434-9

Content Type: article

Copyright: Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.